GAL3ST1 and breast cancer: In breast cancer cell models, the up-regulation of galactosylceramide sulfotransferase, which increases the release of sulfatides from the sphingolipid, was found to be associated with the onset of programed cell death due to the decrease in the amount of the latter acting as an anti-apoptotic molecule (Suchanski et al., 2018[64]).